Page 239 - Manual de Urgencias Pediatría Virgen del Rocío
P. 239
Partes 215-424 4/7/07 11:18 Página 224
224 M.T.Alonso
6. Mandelberg A. Nebulized 3% Hypertonic Caline Solution treatment in hospitalized infants with
viral bronchiolitis. Chest 2003;123:481-487.
7. Lozano JM. Bronchiolitis. Clin Evid 2004;(12):370-84.
8. Wainwright C,Altamirano L, Cheney M.A multicenter, randomized, double-blind, controled trial of
nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349:27-35.
9. Halna M, Leblond P,Aissi E, Dumonceaux A, Delepoulle F, El Kohen R, Hue V, Martinot A. Impact of
the consensus conference on the ambulatory treatment of bronchiolitis in infants. Presse Med
2005;34(4):277-81.
10. Davison C,Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically
ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 2004;5(5):482-9.
11. Kimpen JL. Bronchiolitis: an important health issue. Paediatr Respir Rev 2000;1(3):295-6, 299.
12. Patel H,Platt R,Lozano JM,Wang EE.Glucocorticoids for acute viral bronchiolitis in infants and young
children. Cochrane Database Syst Rev 2004;(3): CD004878.
13. Sarrell E M,Tal G,Witzling M, Someck E, Houri S, Cohen HA, Mandelberg Al. Nebulized 3% hyperto-
nic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms.
Chest 2002;122(6):2015-2020.
14. Mandelberg A,Tal G,Witzling M, Someck E, Houri S, Balin A, Priel IE. Nebulized 3% Hypertonic Sali-
ne Solution Treatment in Hospitalized Infants With Viral Bronchiolitis. Chest 2003;123:481-487.
15. Langley JM, Smith MB, LeBlanc JC, Joudrey H, Ojah CB, Pianosi P. Racemic epinephrine compared to
salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial.
Pediatrics 2005;5:7.
16. Callen M,Torregrosa MJ, Benuda L y Grupo de Vías Respiratorias. Protocolo de Bronquiolitis. Diag-
nóstico y tratamiento en Atención Primaria. Protocolo del GVR (publicación P-GVR-4). Disponible
en www.aepap.org/gvr/protocolos.htm.
17. Myers TR. Use of heliox in children. Respir Care 2006;51(6):619-31.
18. Cambonie G,Milesi C,Fournier-Favre S,Counil F,Jaber S,Picaud JC,Matecki S.Clinical effects of heliox
administration for acute bronchiolitis in young infants. Chest. 2006;129(3):676-82.
19. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368(9532):312-22.
20. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection-a syste-
matic review. Crit Care 2006;10(4):R107.
21. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment
in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med
Assoc J 2006;8(3):169-73.
224 M.T.Alonso
6. Mandelberg A. Nebulized 3% Hypertonic Caline Solution treatment in hospitalized infants with
viral bronchiolitis. Chest 2003;123:481-487.
7. Lozano JM. Bronchiolitis. Clin Evid 2004;(12):370-84.
8. Wainwright C,Altamirano L, Cheney M.A multicenter, randomized, double-blind, controled trial of
nebulized epinephrine in infants with acute bronchiolitis. N Engl J Med 2003; 349:27-35.
9. Halna M, Leblond P,Aissi E, Dumonceaux A, Delepoulle F, El Kohen R, Hue V, Martinot A. Impact of
the consensus conference on the ambulatory treatment of bronchiolitis in infants. Presse Med
2005;34(4):277-81.
10. Davison C,Ventre KM, Luchetti M, Randolph AG. Efficacy of interventions for bronchiolitis in critically
ill infants: a systematic review and meta-analysis. Pediatr Crit Care Med 2004;5(5):482-9.
11. Kimpen JL. Bronchiolitis: an important health issue. Paediatr Respir Rev 2000;1(3):295-6, 299.
12. Patel H,Platt R,Lozano JM,Wang EE.Glucocorticoids for acute viral bronchiolitis in infants and young
children. Cochrane Database Syst Rev 2004;(3): CD004878.
13. Sarrell E M,Tal G,Witzling M, Someck E, Houri S, Cohen HA, Mandelberg Al. Nebulized 3% hyperto-
nic saline solution treatment in ambulatory children with viral bronchiolitis decreases symptoms.
Chest 2002;122(6):2015-2020.
14. Mandelberg A,Tal G,Witzling M, Someck E, Houri S, Balin A, Priel IE. Nebulized 3% Hypertonic Sali-
ne Solution Treatment in Hospitalized Infants With Viral Bronchiolitis. Chest 2003;123:481-487.
15. Langley JM, Smith MB, LeBlanc JC, Joudrey H, Ojah CB, Pianosi P. Racemic epinephrine compared to
salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial.
Pediatrics 2005;5:7.
16. Callen M,Torregrosa MJ, Benuda L y Grupo de Vías Respiratorias. Protocolo de Bronquiolitis. Diag-
nóstico y tratamiento en Atención Primaria. Protocolo del GVR (publicación P-GVR-4). Disponible
en www.aepap.org/gvr/protocolos.htm.
17. Myers TR. Use of heliox in children. Respir Care 2006;51(6):619-31.
18. Cambonie G,Milesi C,Fournier-Favre S,Counil F,Jaber S,Picaud JC,Matecki S.Clinical effects of heliox
administration for acute bronchiolitis in young infants. Chest. 2006;129(3):676-82.
19. Smyth RL, Openshaw PJ. Bronchiolitis. Lancet 2006;368(9532):312-22.
20. Eisenhut M. Extrapulmonary manifestations of severe respiratory syncytial virus infection-a syste-
matic review. Crit Care 2006;10(4):R107.
21. Tal G, Cesar K, Oron A, Houri S, Ballin A, Mandelberg A. Hypertonic saline/epinephrine treatment
in hospitalized infants with viral bronchiolitis reduces hospitalization stay: 2 years experience. Isr Med
Assoc J 2006;8(3):169-73.
